Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Diabetes/Metabolism Research and Reviews|January 16, 2009
What predicts the occurrence of the metabolic syndrome in a population-based cohort of adult healthy subjects?S Bo, R Rosato, G Ciccone, et al.Hormone Research|May 15, 2002
Inverse correlation between insulin-like growth factor (IGF)-binding protein-5 and IGF-I and II during postnatal development of the anterior pituitary glandSilvia González-Parra, Roberto R Rosato, Julie A Chowen, et al.Antimicrobial Agents and Chemotherapy|September 19, 2012
β-Lactams increase the antibacterial activity of daptomycin against clinical methicillin-resistant Staphylococcus aureus strains and prevent selection of daptomycin-resistant derivativesShrenik Mehta, Christopher Singh, Konrad B Plata, et al.Molecular Pharmacology|September 29, 2005
The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramideRoberto R Rosato, Sonia C Maggio, Jorge A Almenara, et al.Pathology|February 28, 2022
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variantAdriana E Rosato, Engy Msiha, Bruce Weng, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 8, 2017
Self-reported adherence to diet and preferences towards type of meal plan in patient with type 2 diabetes mellitus. A cross-sectional studyV Ponzo, R Rosato, E Tarsia, et al.Molecular Cancer Therapeutics|February 20, 2007
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sarah S Kolla, et al.Antimicrobial Agents and Chemotherapy|October 12, 2011
VraSR two-component regulatory system contributes to mprF-mediated decreased susceptibility to daptomycin in in vivo-selected clinical strains of methicillin-resistant Staphylococcus aureusShrenik Mehta, Arabela X Cuirolo, Konrad B Plata, et al.Breast Cancer Research : BCR|September 7, 2018
Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse modelsRoberto R Rosato, Daniel Dávila-González, Dong Soon Choi, et al.European Journal of Pain (London, England)|November 6, 2014
Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough painR Sperlinga, S Campagna, A Berruti, et al.Pageof 10